a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Clinical trial NCT04008888 · UNKNOWN

Trial details

NCT number: NCT04008888
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Multiple Myeloma Plasma Cell Leukemia Extramedullary Plasmacytoma Loss of Chromosome 17p t(14;16)t(4;14)T(14;20)1Q21 Amplification Complex Karyotype

Start date: 2018-01-05
Primary completion: 2020-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.